se of a menthol/ginseng mixture and its possible effects on pain responses in photodynamic therapy.

Phase 2

Completed

• Conditions: Solar Dermopathy; Skin - Dermatological conditions

• Registration Number: ACTRN12612000257864
• Lead Sponsor: Peter Smith

Brief Summary

se of a simple, plant derived anti-nociceptive spray can reduce the discomfort experienced by patients undergoing photodynamic therapy to large areas.

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-03-01
• Study Completion: 2013-04-20
• Last Update Posted: 7 December 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

*All patients male or female older than 21 with mild to moderate solar dermopathy of their face or forearms in whom the managing clinician feels photodynamic therapy to be an appropriate treatment modality
*Must have indicated a willingness to enter the study
*Must have read and fully understood a study information form
*Must have had the opportunity to ask any questions prior to enrolment
*Must have signed study consent form

Exclusion Criteria

*Any contraindications to PDT
*Having received PDT to the treatment area in the last 2years
*Any history of reaction or intolerance to menthol/ginseng mixture or the standard PDT preparation and treatment formulations - alpha hydroxy acid preparations at 10 and 15%.
*Any obvious cutaneous malignancies in the area to receive PDT (these must be appropriately managed before consideration of enrolment in the trial)
*Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified